Angptl4 does not control hyperglucagonemia or α-cell hyperplasia following glucagon receptor inhibition
Haruka Okamoto(Regeneron (United States)), Jesper Gromada(Regeneron (United States))
Cited by 20
Related Papers
Fibroblast Growth Factor-21 Improves Pancreatic β-Cell Function and Survival by Activation of Extracellular Signal–Regulated Kinase 1/2 and Akt Signaling Pathways
|Diabetes|2006|491
Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action
|Journal of Clinical Investigation|2005|107
Genetic Deletion of Trb3, the Mammalian <i>Drosophila tribbles</i> Homolog, Displays Normal Hepatic Insulin Signaling and Glucose Homeostasis
|Diabetes|2007|78
Mice harboring the human <i>SLC30A8</i> R138X loss-of-function mutation have increased insulin secretory capacity
|Proceedings of the National Academy of Sciences|2018|63